
New Delhi, 18 November (H.S.): Union Minister for Agriculture and Farmers Welfare and Rural Development Shivraj Singh Chouhan will dedicate India’s first indigenous inactivated H5N1 (Clade 2.3.2.1a) vaccine for chickens to the nation on November 20. Developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, the vaccine is the first of its kind in the country against the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus belonging to Clade 2.3.2.1a.
According to the Ministry of Agriculture and Farmers Welfare, the vaccine will be dedicated to the nation at ICAR-NIHSAD in Bhopal. It has been developed to protect poultry against the Clade 2.3.2.1a strain of the H5N1 virus circulating in the country.
The ministry said Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu, is a serious disease affecting poultry. Outbreaks can cause mortality rates of nearly 100 per cent among infected birds, resulting in substantial financial losses for poultry farmers due to large-scale culling and trade restrictions. The disease also affects international trade in poultry products, market prices and the livelihoods of farmers.
Since the first detection of the disease in India in 2006, more than 500 combined outbreaks involving the H5N1 and H5N8 subtypes have been reported in the country.
According to the ministry, a major bird flu outbreak could reduce India's gross domestic product (GDP) growth by as much as 1.5 per cent. More than 20 per cent of the country's poultry population could be at risk if the disease spreads unchecked. The 2006 outbreak is estimated to have caused direct and indirect losses of around Rs. 2,200 crore to Rs. 3,000 crore. An outbreak in Manipur also resulted in losses equivalent to 0.5 per cent of the state's GDP.
Bird flu is also a significant public health concern. According to the World Health Organization (WHO), a cumulative 1,003 confirmed human cases of H5N1 avian influenza, including 479 deaths, had been reported across 25 countries, including India, since 2003, as of September 6, 2026.
Studies of the virus have established that the H5N1 strain belonging to Clade 2.3.2.1a has been responsible for most bird flu outbreaks in chickens. In recent years, infections involving this strain have also been detected in several animal species, including mammals. The ministry has additionally cited three human infection cases involving the strain.
Against this backdrop, controlling the spread of the virus is essential not only to minimise financial losses for poultry farmers but also to reduce the risk of transmission from chickens to other animals and humans.
The ministry noted that no specific commercial vaccine is currently available against the H5N1 virus of Clade 2.3.2.1a. The indigenous vaccine developed by ICAR-NIHSAD is therefore an important step towards addressing this gap and strengthening India's capacity to prevent and control bird flu outbreaks in the poultry sector.
---------------
Hindusthan Samachar / Jun Sarkar